About Raciwell Pharma
Raciwell Pharma is a Healthcare company. Manufacturing and marketing of affordable pharmaceutical medicines in India. Its Indian entity Raciwell Pharma Private Limited reported revenue of ₹46.8 Lakh. Raciwell Pharma offers products and services including D3 Today Shots and Enerwin Gold Capsule. Its focus areas include Pharmaceuticals, Drug Manufacturing, Medicine Production and Generic Pharmaceuticals.
Company details
Raciwell Pharma is recognized for formulating and delivering affordable medicines that address urgent medical needs, with a product range exceeding 20 items such as D3 Today Shots and Enerwin Gold Capsule. High-quality standards are maintained through an ISO-certified Quality Assurance Management System, emphasizing trust and client satisfaction. The company, established in 2017 as a Private Limited entity in Mumbai, India, focuses on commercializing accessible health solutions without compromising on efficacy or delivery, thereby aiding community health.
- SectorsHealthcare
- Email••••••••
- Legal Name Raciwell Pharma Pvt. Ltd
- Date of Incorporation 03 Jan, 2017
- Jurisdiction Mumbai, Maharashtra, India
- Indian entity revenue₹46.8 Lakh
FY 2023 · -55% YoY
- Indian entity net loss-₹21.6 Lakh
FY 2023 · -46% margin
- Indian entity EBITDA-₹21.4 Lakh
FY 2023 · -46% margin
Associated legal entities of Raciwell Pharma
Raciwell Pharma operates through Raciwell Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2023) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Raciwell Pharma Private Limited CIN U01100MH2017PTC289219 | Active | 03 Jan 2017 | Mumbai, Maharashtra | ₹0.5 Cr | 3 | View details |
Products & Services of Raciwell Pharma
Raciwell Pharma offers a comprehensive portfolio of products and services, including D3 Today Shots and Enerwin Gold Capsule.
Vitamin D supplements are manufactured for health support, ensuring affordability and accessibility in medical applications
Nutritional capsules are provided for energy enhancement, as part of the product range that is marketed for various health needs
Board of directors of Raciwell Pharma Private Limited (Raciwell Pharma)
Raciwell Pharma Private Limited is the primary company behind Raciwell Pharma. The board of Raciwell Pharma Private Limited currently have 3 directors; the longest-serving is Devendra Nath Mishra, appointed in 2024. 6 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Devendra Nath Mishra DIN 10734438 | Additional Director | 19 Aug 2024 | 2 yrs 2 mo | Raciwell Pharma Private Limited |
| Pooja Dwivedi DIN 10734803 | Additional Director | 19 Aug 2024 | 2 yrs 2 mo | Raciwell Pharma Private Limited |
| Saroj Lata Dwivedi DIN 10871593 | Additional Director | 17 Dec 2024 | 1 yr 10 mo | Raciwell Pharma Private Limited |
Financials of Raciwell Pharma
Figures of Raciwell Pharma Private Limited, the primary company behind Raciwell Pharma, for FY 2023. Revenue was ₹46.8 Lakh (-55% year on year). Net loss was -₹21.6 Lakh (-46% margin). EBITDA was -₹21.4 Lakh (-46% margin). Revenue has grown at a compounded annual rate of -22% over three years and +23% over five years.
- ₹46.8 LakhRevenue · FY 2023 · -55% YoY
- -₹21.6 LakhNet loss · -46% margin
- -₹21.4 LakhEBITDA · -46% margin
- ₹1 LakhPaid-up capital
- -22%Revenue CAGR, 3 years
- +23%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Raciwell Pharma Private Limited are on its company page.
Detailed financial statements for Raciwell Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Raciwell Pharma
The primary company behind Raciwell Pharma, Raciwell Pharma Private Limited, reported revenue of ₹46.8 Lakh for FY 2023, down 55% year on year.
Raciwell Pharma is recognized for formulating and delivering affordable medicines that address urgent medical needs, with a product range exceeding 20 items such as D3 Today Shots and Enerwin Gold Capsule. High-quality standards are maintained through an ISO-certified Quality Assurance Management System, emphasizing trust and client satisfaction. The company, established in 2017 as a Private Limited entity in Mumbai, India, focuses on commercializing accessible health solutions without compromising on efficacy or delivery, thereby aiding community health.
Raciwell Pharma offers D3 Today Shots and Enerwin Gold Capsule.
Raciwell Pharma operates through Raciwell Pharma Private Limited.
The legal entities of Raciwell Pharma currently have 3 directors, including Devendra Nath Mishra, Saroj Lata Dwivedi, Pooja Dwivedi.